Devon, PA-based clinical stage specialty pharmaceutical company, Zynerba Pharmaceuticals, Inc., is making strides in the development of pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. One promising drug in the works is Zygel, a cannabidiol drug created as a permeation-enhanced gel for transdermal delivery. Zynerba Pharmaceuticals, Inc. was formerly known as AllTranz, Inc. before a name change in August 2014. The company was founded in 2007 and is currently run out of Devon, PA.